Publish Date:   May 29, 2024 Type:  Testimony and Comments, Comment Letter Topics:  Data Disaggregation, Health Care Access, Public Health, Medicare Ethnicity: Language:  English State: APIAHF comment letter to the CMS requesting for improvements on the collection and usage of comprehensive race, ethnicity, language, and other demographic data on Medicare Advantage (Part C) beneficiaries and providers. Currently, Medicare Advantage data is not in compliance with OMB standards for federal race and ethnicity data.

Publish Date:   July 2024 Type:  Testimony and Comments, Comment Letter Topics:  Data Disaggregation, Health Care Access, Public Health Ethnicity: Language:  English State: Comment letter submitted by APIAHF to the Office of Minority Health supporting the development of public health vaccine and prevention campaigns involving community health workers (CHWs).

Publish Date: June 2022 Type: Fact Sheet, FAQ, Infographics Topics: Alzheimer's, Brain Awareness, Dementia Ethnicity: Language: English State: Dementia is a brain condition that affects the brain’s functions to control thought, memory, and language. Alzheimer’s is the most common form of dementia, accounting for 60-80% of dementia cases.

VIEW 2023 HEA PHOTOS OUR FOCUS — 2024 START OF YEAR GIVING Donate Now! COVID-19 RESOURCES Culturally and linguistically accessible COVID-19 resources for AA and NH/PI communities TAKE ACTION Help us protect families in the fight for health equity! OUR IMPACT — 35 Serving over 35 years of leadership, advocacy, and movement building 25m APIAHF is a leading voice for over 25 million AAs and NHPIs in the U.S. Working with over 150 community organizations in all states and US territories 150+ Helped enroll nearly 1,000,000 AAs and NHPIs in the ACA 1m LEARN MORE FEATURED RESOURCE APIAHF Comment on Request for Information on Development of Public Health Vaccine and Prevention Education Campaigns Involving Community Health Workers JULY 11, 2024 GO NOW PRESS RELEASE APIAHF Applauds HHS Actions to Expand Healthcare for DACA Recipients MAY 3, 2024 GO NOW WHAT'S HAPPENING Lowering Costs for Asian Americans, Native Hawaiians, and Pacific Islanders: How the Inflation Reduction Act Makes Health Care and Prescription Drugs More Affordable DECEMBER 14, 2023 GO NOW FEATURED RESOURCE APIAHF Comment on HHS Proposed Rule on Discrimination Based on Disability Updated 11-8-2023 NOVEMBER 2023 GO NOW LATEST NEWS — FIRST NAME LAST NAME EMAIL* SIGN UP SUBSCRIBE TO THE APIAHF NEWSLETTER SUBSCRIBE TO THE APIAHF NEWSLETTER

KENT LI SENIOR INFORMATION TECHNOLOGY ASSOCIATE OUR BOARD OUR LEADERSHIP OUR STAFF ABOUT OUR STAFF — Kent Li is the Network Systems Administrator at the Asian & Pacific Islander American Health Forum. Kent is responsible for implementing and managing all IT systems at APIAHF. He oversees all electronic systems and communications infrastructure for the organization including hardware and software, as well as cloud based systems to meet current and projected needs. ​ Kent has over 15 years of experience working in the IT field. Prior to joining APIAHF, Kent has worked as a network consultant for Dan Knox Consulting. ​ Kent has a bachelor degree in Computer Information Systems from San Francisco State University. Next Item Previous Item BACK TO ALL STAFF

PRESS RELEASE BIDEN ADMINISTRATION ANNOUNCES FIRST 10 DRUGS FOR MEDICARE NEGOTIATION AUGUST 29, 2023 WASHINGTON—Today, the Biden administration announced the first round of high-cost prescription drugs for which Medicare will negotiate lower prices as part of the Inflation Reduction Act. “We applaud the Biden administration for taking decisive action to expand benefits and lower drug costs for all Americans,” said Juliet K. Choi, president and CEO of the Asian & Pacific Islander American Health Forum (APIAHF). “We encourage drug manufacturers to work with the Biden administration to make these lifesaving and life-changing products available to recipients of Medicare at a reduced cost. For example, Asian Americans, Native Hawaiians and Pacific Islanders are at higher risk for diabetes, and our communities have already seen the positive impact of insulin costs capped at $35 monthly under the Inflation Reduction Act. The first ten drugs will provide immediate financial relief to millions of hard-working families.” The first 10 drugs are: Eliquis: For prevention and treatment of blood clots Enbrel: For treatment of rheumatoid arthritis, psoriasis and psoriatic arthritis Entresto: For treatment heart failure Farxiga: For treatment of treat diabetes, heart failure and chronic kidney disease Imbruvica: For treatment of blood cancers Fiasp/Novolog: For treatment of diabetes Januvia: For treatment of diabetes Jardiance: For treatment of diabetes and heart failure Stelara: For treatment of psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis Xarelto: For prevention and treatment of blood clots and reduction of risk for patients with coronary or peripheral artery disease To learn more about the Medicare Drug Price Negotiation Program, view the ASPE factsheet and CMS factsheet. # # # The Asian & Pacific Islander American Health Forum (APIAHF) influences policy, mobilizes communities and strengthens programs and organizations to improve the health of Asian Americans, Native Hawaiians and Pacific Islanders. Next Item Previous Item BACK TO PRESS RELEASES